Efficacy and safety of elranatamab in patients with relapsed or refractory multiple myeloma: A US subgroup analysis from MagnetisMM‐3

Overview of attention for article published in Cancer (0008543X), May 2026

Altmetric Badge

About this Attention Score

High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 14 X users

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 20 X posts from 14 X users, with an upper bound of 158,291 followers.

RT @JournalCancer: #OpenAccess article led by our #HemOnc Section Editor @AjayNookaMD | Efficacy and safety of elranatamab in patients with…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 16 additional X posts.